Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
Campus

The SoliRam observational study

Prof. Abdulrahman A. Alshaikh, Professor Physician & Endocrinologist at KAU & DSFH, Chairman of Saudi Scientific Diabetes Society, Saudi Arabia, presents iGlarLixi safety and effectiveness in adults with T2D who fast during Ramadan in Gulf region (SoliRam study sub-analysis).

Related articles
ATTD 2021: Technology Supporting Initiation, Titration, and Intensification
  • Diabetes

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Read article
The InRange Study
  • Diabetes

The InRange Study

Read article
Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options
  • Diabetes

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Read article
MAT-BH-2300251/V1/March2023